These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 725864)

  • 21. Are agents affecting platelet function clinically useful in patients with coronary artery disease?
    Verstraete M
    Acta Clin Belg; 1976; 31(4):229-32. PubMed ID: 1087523
    [No Abstract]   [Full Text] [Related]  

  • 22. [Sulfinpyrazone (Anturane)--new indication: myocardial infarct?].
    Bolte HD
    MMW Munch Med Wochenschr; 1980 Apr; 122(14):507-8. PubMed ID: 6769029
    [No Abstract]   [Full Text] [Related]  

  • 23. [Aftercare of heart infarct patients to reduce the risk of a subsequent infarction].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1983 Apr; 127(16):673-9. PubMed ID: 6134240
    [No Abstract]   [Full Text] [Related]  

  • 24. Platelets and prostaglandins in sudden death: therapeutic implications.
    Gelman JS; Mehta J
    Cardiovasc Clin; 1985; 15(3):65-80. PubMed ID: 2870807
    [No Abstract]   [Full Text] [Related]  

  • 25. Secondary prevention of coronary events after myocardial infarction. Beta-blockers and/or anti-platelets: to whom, when and for how long. A review.
    Bélanger GL; Lavallée JP; Lenis J; Ouellet CA
    Can J Cardiol; 1985 Mar; 1(2):97-105. PubMed ID: 2864991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Summary of design features: clinical trials of platelet-active drugs in cerebrovascular disease.
    Friedman LM
    Circulation; 1980 Dec; 62(6 Pt 2):V88-9. PubMed ID: 7002355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of death from myocardial infarction by aspirin and other platelet active drugs.
    Elwood PC
    Clin Cardiol; 1979 Aug; 2(4):241-5. PubMed ID: 400517
    [No Abstract]   [Full Text] [Related]  

  • 28. The current status of platelet suppressive drugs in the treatment of thrombosis.
    Hirsh J; Gent M; Genton E
    Thromb Diath Haemorrh; 1975 Jun; 33(3):406-16. PubMed ID: 1098213
    [No Abstract]   [Full Text] [Related]  

  • 29. [Sulfinpyrazone (Anturan) after myocardial infarction].
    Faergeman O
    Ugeskr Laeger; 1980 Sep; 142(39):2571-2. PubMed ID: 7445168
    [No Abstract]   [Full Text] [Related]  

  • 30. Myocardial infarction and aspirin.
    N Z Med J; 1980 Aug; 92(665):98. PubMed ID: 6933345
    [No Abstract]   [Full Text] [Related]  

  • 31. Platelet-inhibitory therapy in reconstructive arterial surgery.
    McCollum CN; Goldman M
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():301-9. PubMed ID: 3159216
    [No Abstract]   [Full Text] [Related]  

  • 32. Platelets.
    Hirsh J
    Can Med Assoc J; 1973 Feb; 108(4):416 passim. PubMed ID: 4687370
    [No Abstract]   [Full Text] [Related]  

  • 33. [Role of antiplatelet agents in the prevention of cerebral ischemic accidents].
    Bousser MG
    J Mal Vasc; 1983; 8(1):17-22. PubMed ID: 6341494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac death prevention in post-myocardial infarction patients: a review.
    Boissel JP; Leizorovicz A; Faucomprez C
    Acta Cardiol Suppl; 1980; (25):147-79. PubMed ID: 6103625
    [No Abstract]   [Full Text] [Related]  

  • 35. Preventing death after myocardial infarction.
    Horwitz DL
    Compr Ther; 1980 Jun; 6(6):3-4. PubMed ID: 7379491
    [No Abstract]   [Full Text] [Related]  

  • 36. Can aspirin prevent myocardial infarction?
    Med Lett Drugs Ther; 1975 Mar; 17(6):25-6. PubMed ID: 1092992
    [No Abstract]   [Full Text] [Related]  

  • 37. A controlled study of the effect of sulfinpyrazone on platelet survival and on platelet-bound 14C-serotonin release in patients with previous myocardial infarction.
    Cortellaro M; Boschetti C; Fassio G; Basagni M; Polli EE
    Acta Haematol; 1979; 61(2):68-74. PubMed ID: 217218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
    Genton E
    Circulation; 1980 Dec; 62(6 Pt 2):V111-21. PubMed ID: 6108166
    [No Abstract]   [Full Text] [Related]  

  • 39. Platelet-active drugs in the secondary prevention of cardiovascular events: an overview.
    Weiss HJ
    Circulation; 1980 Dec; 62(6 Pt 2):V41-3. PubMed ID: 7002351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiplatelet and anticoagulant therapy in acute myocardial infarction.
    Jafri SM
    Henry Ford Hosp Med J; 1991; 39(3-4):195-9. PubMed ID: 1804824
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.